Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

9.000 +0.380 (+4.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 101,108
Open 8.730
Bid (Size) 8.720 (1,800)
Ask (Size) 9.300 (300)
Prev. Close 8.620
Today's Range 8.700 - 9.390
52wk Range 6.010 - 17.44
Shares Outstanding 42,957,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-market session. The market value of their outstanding shares is at $77.1 million. Bio-Techne (NASDAQ:TECH)... 
Via Benzinga
News headline image
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference ↗
Adicet Bio (NASDAQ:ACET) outlined its near-term clinical priorities and upcoming data catalysts during a fireside chat at the Jefferies Healthcare Conference in New York, with President and CEO Chen... 
Via MarketBeat

Performance

YTD
+2.0%
+2.0%
1 Month
+11.0%
+11.0%
3 Month
+28.8%
+28.8%
6 Month
+2.0%
+2.0%
1 Year
-8.4%
-8.4%

More News

Read More
News headline image
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces Reverse Stock Split
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 ↗
Via Benzinga
News headline image
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Adicet Bio (ACET) Q2 Loss Widens 3% ↗
Via The Motley Fool
News headline image
Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
From Adicet Bio, Inc.
Via Business Wire

Frequently Asked Questions

Is Adicet Bio, Inc. - Common Stock publicly traded?
Yes, Adicet Bio, Inc. - Common Stock is publicly traded.
What exchange does Adicet Bio, Inc. - Common Stock trade on?
Adicet Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adicet Bio, Inc. - Common Stock?
The ticker symbol for Adicet Bio, Inc. - Common Stock is ACET on the Nasdaq Stock Market
What is the current price of Adicet Bio, Inc. - Common Stock?
The current price of Adicet Bio, Inc. - Common Stock is 9.000
When was Adicet Bio, Inc. - Common Stock last traded?
The last trade of Adicet Bio, Inc. - Common Stock was at 07/02/26 04:00 PM ET
What is the market capitalization of Adicet Bio, Inc. - Common Stock?
The market capitalization of Adicet Bio, Inc. - Common Stock is 386.62M
How many shares of Adicet Bio, Inc. - Common Stock are outstanding?
Adicet Bio, Inc. - Common Stock has 387M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.